📰 Research Models News
Page 7 - Research Models News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Research Models. Real-time updates on events, politics, business and more.
April 12, 2024
Impax Asset Management Group plc decreased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 64.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,115 shares of the medical research company’s stock after […]
April 12, 2024
Harbor Investment Advisory LLC lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 9.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 944 shares of the medical research company’s stock after purchasing an additional […]
April 3, 2024
Dumont & Blake Investment Advisors LLC cut its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,353 shares of the medical research company’s stock after […]
April 3, 2024
Dumont & Blake Investment Advisors LLC cut its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,353 shares of the medical research company’s stock after selling 135 shares during […]
April 2, 2024
Bell Bank lowered its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,716 shares of the medical research company’s stock after selling 146 shares during the quarter. Bell […]
April 2, 2024
Bell Bank cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.8% in the fourth quarter, Holdings Channel reports. The institutional investor owned 1,716 shares of the medical research company’s stock after selling 146 shares during the quarter. Bell Bank’s holdings in Charles River Laboratories International were worth $406,000 at […]
April 2, 2024
Bell Bank decreased its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,716 shares of the medical research company’s stock after selling 146 shares during the period. Bell Bank’s holdings in Charles River […]
March 26, 2024
Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) have received an average rating of “Moderate Buy” from the twelve research firms that are covering the stock, MarketBeat reports. Five analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12 […]
March 26, 2024
Reinhart Partners LLC. lessened its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,895 shares of the medical research company’s stock after selling 16,174 shares […]
March 26, 2024
Reinhart Partners LLC. cut its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.2% in the 4th quarter, Holdings Channel reports. The fund owned 72,895 shares of the medical research company’s stock after selling 16,174 shares during the quarter. Reinhart Partners LLC.’s holdings in Charles River Laboratories International were […]